Literature DB >> 19285069

Additional parameters for the morphometry of angiogenesis and lymphangiogenesis in corneal flat mounts.

S Blacher, B Detry, F Bruyère, J-M Foidart, A Noël.   

Abstract

Mesh：

Year:  2009        PMID： 19285069     DOI： 10.1016/j.exer.2009.02.021

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  8 in total

1.  The role of fatty acid β-oxidation in lymphangiogenesis.

Authors:  Brian W Wong; Xingwu Wang; Annalisa Zecchin; Bernard Thienpont; Ivo Cornelissen; Joanna Kalucka; Melissa García-Caballero; Rindert Missiaen; Hongling Huang; Ulrike Brüning; Silvia Blacher; Stefan Vinckier; Jermaine Goveia; Marlen Knobloch; Hui Zhao; Cathrin Dierkes; Chenyan Shi; René Hägerling; Veronica Moral-Dardé; Sabine Wyns; Martin Lippens; Sebastian Jessberger; Sarah-Maria Fendt; Aernout Luttun; Agnès Noel; Friedemann Kiefer; Bart Ghesquière; Lieve Moons; Luc Schoonjans; Mieke Dewerchin; Guy Eelen; Diether Lambrechts; Peter Carmeliet
Journal:  Nature       Date:  2016-12-26       Impact factor: 49.962

2.  Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis.

Authors:  Odeta Meçe; Diede Houbaert; Maria-Livia Sassano; Tania Durré; Hannelore Maes; Marco Schaaf; Sanket More; Maarten Ganne; Melissa García-Caballero; Mila Borri; Jelle Verhoeven; Madhur Agrawal; Kathryn Jacobs; Gabriele Bergers; Silvia Blacher; Bart Ghesquière; Mieke Dewerchin; Johan V Swinnen; Stefan Vinckier; María S Soengas; Peter Carmeliet; Agnès Noël; Patrizia Agostinis
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

3.  Does plasminogen activator inhibitor-1 drive lymphangiogenesis?

Authors:  Françoise Bruyère; Laurence Melen-Lamalle; Silvia Blacher; Benoît Detry; Anne Masset; Julie Lecomte; Vincent Lambert; Catherine Maillard; Gunilla Høyer-Hansen; Leif R Lund; Jean-Michel Foidart; Agnès Noël
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

4.  Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival.

Authors:  Mohammad H Dastjerdi; Daniel R Saban; Andre Okanobo; Nambi Nallasamy; Zahra Sadrai; Sunil K Chauhan; Amir R Hajrasouliha; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

5.  Digging deeper into lymphatic vessel formation in vitro and in vivo.

Authors:  Benoit Detry; Françoise Bruyère; Charlotte Erpicum; Jenny Paupert; Françoise Lamaye; Catherine Maillard; Bénédicte Lenoir; Jean-Michel Foidart; Marc Thiry; Agnès Noël
Journal:  BMC Cell Biol       Date:  2011-06-24       Impact factor: 4.241

6.  ADAMTS2 and ADAMTS14 can substitute for ADAMTS3 in adults for pro-VEGFC activation and lymphatic homeostasis.

Authors:  Laura Dupont; Loïc Joannes; Florent Morfoisse; Silvia Blacher; Christine Monseur; Christophe F Deroanne; Agnès Noël; Alain Cma Colige
Journal:  JCI Insight       Date:  2022-04-22

7.  Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.

Authors:  Melissa García-Caballero; Jenny Paupert; Silvia Blacher; Maureen Van de Velde; Ana Rodríguez Quesada; Miguel Angel Medina; Agnès Noël
Journal:  J Hematol Oncol       Date:  2017-06-19       Impact factor: 17.388

8.  uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.

Authors:  Tania Durré; Florent Morfoisse; Charlotte Erpicum; Marie Ebroin; Silvia Blacher; Melissa García-Caballero; Christophe Deroanne; Thomas Louis; Cédric Balsat; Maureen Van de Velde; Seppo Kaijalainen; Frédéric Kridelka; Lars Engelholm; Ingrid Struman; Kari Alitalo; Niels Behrendt; Jenny Paupert; Agnès Noel
Journal:  Nat Commun       Date:  2018-12-05       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.